Loading
Diagnosis information
Core diagnostic criteria, specifiers, differential considerations, and documentation support in one open, scan-friendly view.
All criteria are shown. No expand controls or hidden sections.
Core criterion A
Medication-induced movement symptoms causing clinically significant distress or impairment
Core criterion B
Does not meet criteria for another specific medication-induced movement disorder (NMS, acute dystonia, acute akathisia, tardive dyskinesia, tardive dystonia/akathisia, parkinsonism, postural tremor)
Consistent with [Other Medication-Induced Movement Disorder] [specifier(s)]. Following recent initiation, dose escalation, dose reduction, or withdrawal of an implicated medication, there has been the emergence of abnormal involuntary movements; abnormal voluntary motor patterns; changes in muscle tone or posture; motor phenomena not otherwise classifiable as parkinsonism, acute dystonia, akathisia, tardive dyskinesia, tardive dystonia, or tremor, forming a medication-related movement syndrome with a clear temporal association to medication exposure. The presentation is further characterised by a phenomenology inconsistent with a specific named medication-induced movement disorder and clinical features not meeting full criteria for a defined movement disorder subtype. These symptoms have resulted in clinically significant distress or impairment, and the pattern is best explained by a medication-induced movement disorder rather than a primary neurological movement disorder, primary psychiatric agitation, substance intoxication or withdrawal, delirium, or a general medical condition.
Adapt this supplied template to the assessment. It is not a substitute for diagnostic reasoning or local documentation requirements.